{"id":2787,"date":"2024-01-08T21:25:34","date_gmt":"2024-01-08T21:25:34","guid":{"rendered":"https:\/\/assistinghands.com\/98\/?p=2787"},"modified":"2026-05-07T22:25:58","modified_gmt":"2026-05-07T22:25:58","slug":"senior-with-parkinsons","status":"publish","type":"post","link":"https:\/\/assistinghands.com\/98\/ohio\/westlake\/blog\/senior-with-parkinsons\/","title":{"rendered":"How Long Can a Senior Live with Parkinson’s Disease"},"content":{"rendered":"

A timeline of survival with Parkinson\u2019s disease is highly correlated with age. When certain risk factors are present, the lifespan of a Parkinson’s patient can range anywhere from 2 to 37 years from diagnosis.<\/strong> Identifying risk factors that lead to early death can help increase a senior\u2019s life expectancy.<\/p>\n

What is Parkinson\u2019s disease?<\/h2>\n

Parkinson\u2019s disease is a neurodegenerative disorder that affects the brain\u2019s dopamine-producing neurons. The condition normally occurs after age 60 and is thought to be caused by genetic and environmental factors. A cure is currently unavailable, but various treatments can significantly improve symptoms.<\/p>\n

What are symptoms of Parkinson\u2019s disease?<\/h2>\n

At the onset of Parkinson\u2019s disease, symptoms begin slowly. A senior might experience a tremor in one hand, for instance. As the disease progresses, facial expressions become stiff. The senior\u2019s arm may no longer swing when he walks. Speech becomes soft or slurred.<\/p>\n

Along with tremors, patients experience slowness in movement. Their steps become shorter or they may drag their feet as they walk. The rigid muscles that occur in seniors with Parkinson\u2019s limit their range of motion. Patients stoop, resulting in impaired posture and balance.<\/p>\n

As the disease progresses, affected older adults lose their ability to perform automatic movements, like blinking and smiling. Rather than animated, patients\u2019 speech patterns sound monotone. Handwriting also becomes smaller and more difficult in people who live with Parkinson\u2019s disease.<\/p>\n

\"home<\/a><\/p>\n

What is the life expectancy for Parkinson\u2019s patients?<\/h2>\n

Seniors with Parkinson\u2019s<\/a> enjoy a fairly normal lifespan than those without the condition. Overall life expectancy hovers between the ages of 78 and 81, with age and location being dependent factors. Older adults who live to 65 have a longer life expectancy at 84 to 86 years.<\/p>\n

What is the life expectancy after a Parkinson\u2019s diagnosis?<\/h2>\n

The age of onset is a determining factor in life expectancy. When symptoms appear between the ages of 40 and 65, the senior\u2019s average life expectancy is reduced from 31 to 21 years. When onset is after age 65, the average life expectancy is reduced from 9 to 5 years.<\/p>\n

When the duration of Parkinson\u2019s disease is long, it may be concluded that patients eventually become significantly disabled and are prone to health complications. The actual survival rate of older adults living with Parkinson\u2019s disease differs as a result of several factors.<\/p>\n

Parkinson\u2019s disease itself is not fatal. However, symptoms of the condition can cause issues that affect mortality. An older patient\u2019s risk for falls, for instance, increases with the severity of tremors, muscle weakness, and other mobility issues. Bedbound seniors are more at risk for life-threatening blood clots.<\/p>\n

Seniors who experience psychotic symptoms, such as delusions and hallucinations, also have a higher likelihood of dying earlier than Parkinson\u2019s patients without these symptoms. Taking antipsychotic drugs or drugs for Parkinson\u2019s disease have no adverse effect on a patient\u2019s mortality.<\/p>\n

Dementia patients with Parkinson\u2019s are two times more likely to die earlier than people without memory issues. Men are 1.6 times more likely to die sooner from Parkinson\u2019s disease than women. People who score low on movement tests have a higher risk of dying earlier than those who score high.<\/p>\n

\"Senior<\/p>\n

How do Parkinson\u2019s patients increase their life expectancy?<\/h2>\n

Living longer with Parkinson\u2019s disease can be partially achieved by preventing or delaying the advancement of movement problems, psychosis, and dementia. Medications slow progression of the disease. New drugs have been developed to treat Parkinson\u2019s disease and older ones are better understood.<\/p>\n

1. Parkinson\u2019s Medications<\/h3>\n

One of the most common drugs for Parkinson\u2019s disease is levodopa, which controls slow movements and rigid body parts. The brain cells change levodopa to a chemical known as dopamine (which Parkinson\u2019s patients don\u2019t have enough of) so that the brain successfully sends signals to move the body.<\/p>\n

Amantadine is another commonly prescribed drug for Parkinson\u2019s patients. This drug raises the amount of dopamine in the brain, resulting in the senior experiencing fewer symptoms. Amantadine is generally more helpful for aging adults who live with mild Parkinson\u2019s disease.<\/p>\n

New Advances in Parkinson\u2019s Medications<\/h4>\n

Vyalev has received FDA approval as a groundbreaking treatment for advanced Parkinson\u2019s disease, offering a new hope for patients facing the later stages of the disease. Here are some key details about this treatment:<\/p>\n